Able Medical to Showcase Industry’s First-to-Market PEEK Sternal Closure System at STS
Able Medical to Showcase Industry’s First-to-Market PEEK Sternal Closure System at STS
Able Medical’s Valkyrie Thoracic Fixation System uses PEEK (polyether ether ketone) to provide surgeons with a strong, lightweight and biocompatible alternative to traditional metal implants. PEEK’s radiolucency and flexibility make it an ideal material for patients who require stability, comfort and improved visualization during the healing process.
MARQUETTE, Mich.--(BUSINESS WIRE)--Able Medical Devices, a leading innovator and the first company to introduce a PEEK rigid fixation system for sternal closure, today announced it will showcase its latest sternal closure solutions at the Society of Thoracic Surgeons (STS) 2026 Annual Meeting in New Orleans, Louisiana. The company’s advanced PEEK-based sternal closure technology reflects its ongoing commitment to improving patient outcomes and surgical efficiency.
Able Medical’s sternal closure system uses PEEK providing a strong, lightweight and biocompatible alternative to traditional metal implants. PEEK’s radiolucency and flexibility make it an ideal material for stability, comfort and improved visualization.
Share
Able Medical’s sternal closure system utilizes PEEK (polyether ether ketone) to provide surgeons with a strong, lightweight and biocompatible alternative to traditional metal implants. PEEK’s radiolucency and flexibility make it an ideal material for patients who require stability, comfort and improved visualization during the healing process.
“We’re excited to be among the first to bring a PEEK sternal closure system to market,” said Peter Didyk, SVP & managing director at Able Medical. “Our team’s collaboration with surgeons and engineers have driven the development of a solution that enhances patient care while simplifying the surgical experience for the cardiothoracic O.R. teams.”
Able Medical will exhibit its PEEK sternal closure products at STS 2026, taking place January 29 – February 1, 2026, in New Orleans, Louisiana. Attendees are invited to visit Able Medical at booth 1009 to learn more about the company’s sternal closure platform, upcoming innovations and custom design capabilities.
About Able Medical Devices
Able Medical Devices, headquartered in Marquette, Michigan, is a global partner to the orthopedic and broader medical device industry. As a subsidiary of J.M. Longyear, a privately held Michigan-based investment and asset management company, Able Medical benefits from a strong legacy of operational excellence and long-term investment support.
The company is recognized as a leader in cardiothoracic products, including thoracic fixation and sternal closure solutions. Able Medical’s expertise extends across spine, trauma and cardiothoracic applications, where it works closely with surgeons to bring precision-engineered, next-generation solutions to market.
For more information, visit www.AbleMedicalDevices.com.
Contacts
Media Contact
Jeffrey Gilhool
Senior Director of Marketing
Able Medical Devices
Email: jeffreyg@abledev.us
Phone: (906) 373-9539
Website: www.AbleMedicalDevices.com

